Daclatasvir and asunaprevir for genotype 1b chronic hepatitis C patients with chronic kidney disease.
about
Systematic review with meta-analysis: effectiveness and tolerability of interferon-free direct-acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia.Improvement of Proteinuria due to Combination Therapy with Daclatasvir and Asunaprevir in Hepatitis C Virus-associated Renal Disease without Cryoglobulinemia: A Case Report.
P2860
Daclatasvir and asunaprevir for genotype 1b chronic hepatitis C patients with chronic kidney disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Daclatasvir and asunaprevir fo ...... s with chronic kidney disease.
@en
type
label
Daclatasvir and asunaprevir fo ...... s with chronic kidney disease.
@en
prefLabel
Daclatasvir and asunaprevir fo ...... s with chronic kidney disease.
@en
P2093
P2860
P356
P1433
P1476
Daclatasvir and asunaprevir fo ...... s with chronic kidney disease.
@en
P2093
Akihito Tsubota
Chisa Kondo
Etsuko Iio
Hiroshi Abe
Kai Yoshizawa
Katsuhiko Iwakiri
Masanori Atsukawa
Noritomo Shimada
Tomomi Okubo
Toru Asano
P2860
P356
10.1111/HEPR.12879
P577
2017-02-22T00:00:00Z